NCT02627508View on ClinicalTrials.gov

Pilot Trial of Pregnenolone in Autism

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 29, 2016

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Autism Spectrum DisorderAutism
Interventions
DRUG

Pregnenolone

orally administered Pregnenolone capsules

DRUG

Placebo

orally administered placebo capsules

Trial Locations (1)

94305

RECRUITING

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

Simons Foundation

OTHER

lead

Stanford University

OTHER

NCT02627508 - Pilot Trial of Pregnenolone in Autism | Biotech Hunter | Biotech Hunter